Observational studyScientific reports2024

Intravenous high-dose anakinra drops venous thrombosis and acute coronary syndrome in severe and critical COVID-19 patients: a propensity score matched study.

Ramazan Çakmak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.